{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:34:13Z","timestamp":1787841253877,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Valproic acid (VPA) is the medication prescribed for the treatment of bipolar disorder, epilepsy, and migraine. It is reported that the VPA treatment leads to biotin deficiency due to the low serum biotinidase activity. Alopecia or hair loss is another common side effect of valproate administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The study aims to investigate hair loss complaint in people, who are on Valproate and find the association between valproate levels, serum biotinidase activity and hair loss in persons treated with valproate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This two years cross sectional comparative study involving 150 participants was performed at department of Psychiatry of a tertiary care teaching hospital. The study group had 75 persons taking Valproate compared with 75 persons in the control group. Blood samples were collected for estimation of serum VPA levels and serum biotinidase activity. Quantification of alopecia biomarker Interleukin (IL)-2 was estimated. Data was analyzed by using student T test, Pearson\u2019s correlation, and Mann Whitney\n                      <jats:italic toggle=\"yes\">U<\/jats:italic>\n                      test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study group comprised of 40 males and 35 females with a mean age of 42.04 (\u00b112.85) years. The control group had 39 males and 36 females with a mean age of 38.38 (\u00b114.42) years. Hair loss was reported in 18 (24%) persons of study cohort compared to 2 (2.66%) among the control group. There was a statistically significant difference between biotinidase levels across the participants with hair loss complaint and those without hair loss complaint. (Mean rank of participants with hair loss complaint = 43.30, mean rank of participants without hair loss complaint = 80.45, U = 656.000,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2264 0.001). There was a statistically significant difference between the distribution of\n                      <jats:italic toggle=\"yes\">IL2<\/jats:italic>\n                      across the study and control groups. (Mean rank of study group = 57.73, mean rank of control group = 83.27, U = 3,395.00,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.025).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>It can be concluded that there is an association between Valproate levels, biotinidase activity and hair loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/indianjpsychiatry_1152_24","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:01:41Z","timestamp":1758031301000},"page":"894-899","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Study of association between valproic acid levels, biotinidase activity and hair loss in Indian population: A cross-sectional comparative study"],"prefix":"10.4103","volume":"67","author":[{"given":"Anil","family":"Kakunje","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Yenepoya Medical College, Yenepoya Deemed to be University, Mangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Prabhu","sequence":"additional","affiliation":[{"name":"Division of Cancer Research and Therapeutics, Yenepoya Research Center, Yenepoya Deemed to be University, Mangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravichandra","family":"Karkal","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yenepoya Medical College, Yenepoya Deemed to be University, Mangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Rahyanath","family":"Pookoth","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yenepoya Medical College, Yenepoya Deemed to be University, Mangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmod","family":"Kumar","sequence":"additional","affiliation":[{"name":"Consultant Psychiatrist, Parmod Clinic, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Gupta","sequence":"additional","affiliation":[{"name":"Consultant Psychiatrist, Gupta Mind Healing and Counseling Center, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ES Sindhu","family":"Priya","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Yenepoya Pharmacy College and Research Centre, Mangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PMA","family":"Nishad","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yenepoya Medical College, Yenepoya Deemed to be University, Mangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"R1-20250916","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2174\/092986707782360088","article-title":"Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: A review","volume":"14","author":"Reynolds","year":"2007","journal-title":"Curr Med Chem"},{"key":"R2-20250916","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-5793(03)00350-8","article-title":"Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: A role of histone deacetylase inhibition","volume":"542","author":"Jeong","year":"2003","journal-title":"FEBS"},{"key":"R3-20250916","doi-asserted-by":"crossref","first-page":"16659","DOI":"10.1073\/pnas.0407643101","article-title":"Histonedeacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells","volume":"101","author":"Hsieh","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"R4-20250916","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(02)00299-1","article-title":"Lithium and valproic acid: Parallels and contrasts in diverse signaling contexts","volume":"96","author":"Gurvich","year":"2002","journal-title":"Pharmacol Ther"},{"key":"R5-20250916","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.seizure.2013.04.015","article-title":"Molecular mechanisms of antiseizure drug activity at GABA A receptors","volume":"22","author":"Greenfield","year":"2013","journal-title":"Seizure"},{"key":"R6-20250916","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.braindev.2008.07.008","article-title":"The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administered with valproic acid","volume":"31","author":"Arslan","year":"2013","journal-title":"Brain Dev"},{"key":"R7-20250916","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1046\/j.1528-1157.2001.47000.x","article-title":"Low serum biotinidase activity in children with valproic acid monotherapy","volume":"42","author":"Schulpis","year":"2001","journal-title":"Epilepsia"},{"key":"R8-20250916","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejpn.2008.08.007","article-title":"The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity","volume":"13","author":"Yilmaz","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"key":"R9-20250916","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4103\/0253-7613.169587","article-title":"Dose-dependent valproate-induced alopecia in patients with mental disorders","volume":"47","author":"Tomita","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"R10-20250916","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0253-7613.108315","article-title":"Serum drug level-related sodium valproate-induced hair loss","volume":"45","author":"Ramakrishnappa","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"R11-20250916","first-page":"112","article-title":"Sodium valproate induced alopecia in a patient of epilepsy","volume":"15","author":"Panwar","year":"2016","journal-title":"IOSR J Dent Med Sci"},{"key":"R12-20250916","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/0883073809336118","article-title":"Serum biotinidase activity in children treated with valproic acid and carbamazepine","volume":"25","author":"Castro-Gago","year":"2010","journal-title":"J Child Neurol"},{"key":"R13-20250916","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1097\/00004714-199202001-00008","article-title":"Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients","volume":"12","author":"Calabrese","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"R14-20250916","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.48.1.182","article-title":"Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: A double-blind concentration response design clinical trial. Depakote monotherapy for partial seizures study group","volume":"48","author":"Beydoun","year":"1997","journal-title":"Neurology"},{"key":"R15-20250916","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/ijt.ijt_10_18","article-title":"Valproate: It\u2019s effect on hair","volume":"10","author":"Kakunje","year":"2018","journal-title":"Int J Trichol"},{"key":"R16-20250916","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2019.04.003","article-title":"Risk of valproic acid related alopecia: A systematic review and meta-analysis","volume":"69","author":"Wang","year":"2019","journal-title":"Seizure"},{"key":"R17-20250916","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yebeh.2014.10.021","article-title":"Cosmetic side effects of anti-epileptic drugs in adults with epilepsy","volume":"42","author":"Chen","year":"2015","journal-title":"Epilepsy Behav"},{"key":"R18-20250916","doi-asserted-by":"crossref","first-page":"e2814","DOI":"10.1002\/hup.2814","article-title":"Valproate-associated hair abnormalities: Pathophysiology and management strategies","volume":"37","author":"Praharaj","year":"2022","journal-title":"Hum Psychopharmacol"},{"key":"R19-20250916","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00007691-198703000-00007","article-title":"Long term treatment with sodium valproate: Monitoring of venous ammonia concentration and adverse effects","volume":"9","author":"Zaccara","year":"1987","journal-title":"Ther Drug Monit"},{"key":"R20-20250916","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/ijt.ijt_53_18","article-title":"Development of pityriasis amiantacea after valproic acid therapy","volume":"10","author":"Diaz-Perez","year":"2018","journal-title":"Int J Trichol"},{"key":"R21-20250916","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/amhs.amhs_228_20","article-title":"A perspective on predictive markers of alopecia","volume":"8","author":"Kakunje","year":"2020","journal-title":"Arch Med Health Sci"},{"key":"R22-20250916","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2460\/javma.2001.218.1587","article-title":"Hyperactivity and alopecia associated with ingestion of valproic acid in a cat","volume":"218","author":"Zoral","year":"2001","journal-title":"J Am Vet Med Assoc"},{"key":"R23-20250916","first-page":"FR01","article-title":"Sodium valproate induced alopecia: A case series","volume":"11","author":"Thomson","year":"2017","journal-title":"J Clin Diagn Res"}],"container-title":["Indian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/indianjpsychiatry_1152_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:46:52Z","timestamp":1787838412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/indianjpsychiatry_1152_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/indianjpsychiatry_1152_24","relation":{},"ISSN":["0019-5545","1998-3794"],"issn-type":[{"value":"0019-5545","type":"print"},{"value":"1998-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2024-12-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}